Učitavanje...
Aflibercept efficacy in refractory choroidal neovascularization
The aim of the report is to evaluate the short-term efficacy and safety of aflibercept (EYLEA®) in patients with choroidal neovascularization (CNV) transformed into refractory during treatment with bevacizumab (AVASTIN ®). Methods: Clinical, morphological, and functional changes were retrospectively...
Spremljeno u:
| Izdano u: | Rom J Ophthalmol |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Romanian Society of Ophthalmology
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5711372/ https://ncbi.nlm.nih.gov/pubmed/29450330 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|